FeudtnerC. Ethics in the midst of therapeutic evolution. Arch Pediatr Adolesc Med. 2008;162:854-857.
2.
EmaniSMMcElhinneyDBTworetzkyW. Staged left ventricular recruitment after single-ventricle palliation in patients with borderline left heart hypoplasia. J Am Coll Cardiol. 2012;60:1966-1974.
3.
SistinoJJBonilhaHS. Improvements in survival and neurodevelopmental outcomes in surgical treatment of hypoplastic left heart syndrome: a meta-analytic review. J Extra Corpor Technol. 2012;44:216-223.
4.
RavishankarCZakVWilliamsIA; Pediatric Heart Network Investigators. Association of impaired linear growth and worse neurodevelopmental outcome in infants with single ventricle physiology: a report from the Pediatric Heart Network infant single ventricle trial. J Pediatr. 2013;162:250.e2-256.6e2.
5.
CrossRRHarahshehASMcCarterRMartinGR; for the National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC). Identified mortality risk factors associated with presentation, initial hospitalisation, and interstage period for the Norwood operation in a multi-centre registry: a report from the National Pediatric Cardiology–Quality Improvement Collaborative [published online February 6, 2013]. Cardiol Young. doi:10.1017/S1047951113000127.
6.
HansenJHFurckAKPetkoC. Use of surveillance criteria reduces interstage mortality after the Norwood operation for hypoplastic left heart syndrome. Eur J Cardiothorac Surg. 2012;41:1013-1018.
7.
KulkarniSRaoS. Definitive therapy for hypoplastic left heart syndrome—Indian scenario. Indian Heart J. 2012;64:338-340.